(2024, September) Retatrutide is a novel triple-agonist targeting GLP-1, GIP, and glucagon receptors, showing in phase 2 trials that it can deliver remarkably large weight losses (up to ~24% over 48 weeks in people with obesity) along with strong improvements in HbA1c, lipid profiles, liver fat (in NAFLD), insulin sensitivity, and other cardiometabolic markers
Taking these supplements may lead to elevated thyroid hormone levels in the blood and cause symptoms of hyperthyroidism, which can lead to dangerous complications (12Trusted Source, 13Trusted Source, 14Trusted Source)
- Gas or bloating in sensitive individuals
Key Points About Semaglutide and Weight Loss Its important to note that while semaglutide may be effective for weight loss, it is not a standalone solution
Our physicians take the time to review your full health history and create a protocol tailored to your body
El uso de frmacos anlogos del GLP-1 est asociado con beneficios pero tambin riesgos para la salud El uso de agonistas del receptor del pptido similar al glucagn tipo 1 (GLP-1RAs, por sus siglas en ingls), utilizados para tratar la diabetes y la obesidad, podra estar asociado con un amplio espectro de efectos sobre la salud, tanto positivos como un menor riesgo de trastornos cardiometablicos como negativos un mayor riesgo de afecciones gastrointestinales o hipertensin
